Data / Form D filings / Ostentus Therapeutics, Inc.
Ostentus Therapeutics, Inc.: Form D filings
Ostentus Therapeutics, Inc., a health care company in Newport Coast, CA, filed 5 Form D notices with the SEC between 2021 and 2024. The latest, on March 8, 2024, reports $150,000 sold of a $9.8 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 12 GENTLE BREEZE, Newport Coast, CA, 92657
- Phone
- (714) 658-6562
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- California
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1901024
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 8, 2024 | New notice | $9,800,000 | $150,000 | $9,650,000 | 2 | Feb 24, 2024 | sec.gov |
| Oct 13, 2022 | New notice | $770,000 | $520,000 | $250,000 | 7 | Oct 4, 2022 | sec.gov |
| Oct 6, 2022 | New notice | $487,500 | $487,500 | 4 | Sep 28, 2022 | sec.gov | |
| Jan 26, 2022 | New notice | $7,500,000 | $100,000 | $7,400,000 | 1 | Jan 25, 2022 | sec.gov |
| Dec 23, 2021 | New notice | $500,000 | $500,000 | 5 | Dec 13, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| William Graff | Director, Promoter | |
| Elisabetta Graff | Executive Officer, Director, Promoter | |
| Stuart Weinstein | Director, Promoter |
Other health care companies in California that filed recently
- VERIONYX, INC. offering · Oct 26, 2026
- RCE Technologies, Inc. $110,000 · Oct 23, 2026
- Gale Force Aesthetics, Inc. $800,000 · Oct 22, 2026
- VahatiCor, Inc. $30.4 million · Oct 20, 2026
- Lamina Surgical, Inc. $490,000 · Oct 16, 2026
- Ellipsys Medical, Inc. $8.6 million · Oct 14, 2026
Every Form D from the week of Mar 4, 2024 · All recent filings in California · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Ostentus Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.